Wound Insert with Reactive Polymer for Controlled Antimicrobial Release

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current wound treatment methods, particularly negative pressure wound therapy, face challenges in effectively delivering antimicrobial agents to wounds without causing systemic damage or side effects, and existing methods for generating hypochlorous acid are costly, complex, or chemically unstable.

Innovation Solution

The development of wound inserts comprising open-celled foam with reactive agents, such as hypochlorite salts, that react with water to release hypochlorite ions or hypochlorous acid, which are encapsulated in biocompatible polymers to ensure controlled release and stability, allowing for effective antimicrobial action at the wound site.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If hypochlorous acid is generated using existing methods, then antimicrobial action is achieved, but the process becomes costly, complex, and chemically unstable

Engineering Contradiction:
Improvechemical stabilityVSAvoidgeneration process complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent applies preliminary action by pre-encapsulating hypochlorite salts within biocompatible polymer matrices during manufacturing. This allows the antimicrobial agent to be prepared in a stable, inert form that only activates upon contact with wound exudate or applied moisture, eliminating the need for complex generation equipment and ensuring chemical stability during storage and transport.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses biocompatible polymers as intermediaries to encapsulate and control the release of hypochlorite salts. These polymer matrices act as mediators that protect the reactive hypochlorite from premature decomposition while allowing controlled release upon contact with physiological fluids, thereby simplifying the overall system and improving stability without compromising antimicrobial efficacy.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Reliability

If antimicrobial agents are delivered systemically, then infection control is achieved, but systemic damage and side effects occur

Engineering Contradiction:
Improveinfection control efficacyVSAvoidsystemic side effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent applies local quality by designing a wound insert that delivers antimicrobial agents exclusively at the wound site through localized encapsulation and controlled release mechanisms. The hypochlorite-containing polymer matrix is placed directly in contact with the wound, ensuring high concentration antimicrobial action locally while preventing systemic absorption and associated side effects.

Inventive Principle:
Principle #3Local quality

Solution Approach 2:

The wound insert employs self-service by utilizing the wound's own exudate or applied moisture to trigger the release of hypochlorite from the polymer encapsulation. This self-activating mechanism ensures the antimicrobial agent is released precisely where needed without requiring external delivery systems that could cause systemic exposure.

Inventive Principle:
Principle #25Self-service

3Productivity

If reactive agents are released immediately, then antimicrobial action is maximized, but uncontrolled release causes instability and reduced effectiveness

Engineering Contradiction:
Improveantimicrobial action speedVSAvoidreactive agent stability
Core Design Contradiction:
ProductivityVSStability of the object's composition

Solution Approach 1:

The patent applies dynamics by creating a polymer encapsulation system that transitions from a stable, inactive state during storage to an active, releasing state upon contact with physiological fluids. The dynamic response is triggered by changes in the local environment (moisture, pH, temperature) at the wound site, allowing the system to maintain stability until needed and then release the antimicrobial agent rapidly and controllably.

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent utilizes parameter changes by designing the polymer encapsulation to respond to specific physiological parameters (such as pH changes, moisture content, or temperature) at the wound site. These parameter changes trigger the release of hypochlorite from the polymer matrix, ensuring stable storage under one set of conditions and controlled, rapid release under another set of conditions, thereby maximizing both stability and antimicrobial effectiveness.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This solution provides a controlled and effective delivery of antimicrobial agents directly to the wound, enhancing infection control and wound healing while avoiding systemic side effects and reducing the complexity and cost of antimicrobial solution generation and storage.

Implementation Method 1

reactive agents, such as hypochlorite salts, that react with water to release hypochlorite ions or hypochlorous acid

Methodology Applied
Scientific EffectChemical reaction: Chemical Bonding

Data Source

PatentUS11167059B2Compositions with reactive ingredients, and wound dressings, apparatuses, and methods
Publication Date: 2021.11.09 SOLVENTUM INTELLECTUAL PROPERTIES CO
  • US11167059B2 patent drawing
  • US11167059B2 patent drawing
  • US11167059B2 patent drawing

AI summary

Wound dressings and wound inserts comprising substantially dry reactive agents, methods of forming wound inserts comprising dry reactive agents, and wound-treatment methods.